enow.com Web Search

Search results

  1. Results from the WOW.Com Content Network
  2. GlaxoSmithKline Carbon Neutral Laboratory - Wikipedia

    en.wikipedia.org/wiki/GlaxoSmithKline_Carbon...

    The Carbon Neutral Laboratory was designed to minimise the impact on the environment of its construction and operation. The design of the building is made up of modules manufactured off-site. The building support pillars and trusses are made from a combination of German spruce , Austrian Spruce, and American red cedar . [ 7 ]

  3. GSK plc - Wikipedia

    en.wikipedia.org/wiki/GSK_plc

    GSK plc (an acronym from its former name GlaxoSmithKline plc) is a British multinational pharmaceutical and biotechnology company with headquarters in London. [3] [4] It was established in 2000 by a merger of Glaxo Wellcome and SmithKline Beecham, [n 1] which was itself a merger of a number of pharmaceutical companies around the Smith, Kline & French firm.

  4. GSK's experimental drug shows promise in reducing severe ...

    www.aol.com/news/gsks-experimental-drug-shows...

    (Reuters) -GSK's experimental drug met its primary goal of reducing asthma attacks in a late-stage trial, marking a bright spot for a treatment that the British drugmaker expects to make peak ...

  5. Study confirms GSK-Vir antibody drug reduces ... - AOL

    www.aol.com/finance/study-confirms-gsk-vir...

    In a study of 1,057 patients, sotrovimab resulted in a 79% reduction in risk of hospitalization for more than 24 hours or death due to any cause, the companies said on Monday. Sotrovimab belongs ...

  6. GSK's asthma drug Nucala meets main goal in study on ... - AOL

    www.aol.com/news/gsks-asthma-drug-nucala-meets...

    (Reuters) -British drugmaker GSK said on Friday that its asthma drug, Nucala, met the main goal of a late-stage study in treating patients with chronic obstructive pulmonary disease (COPD), or ...

  7. Study 329 - Wikipedia

    en.wikipedia.org/wiki/Study_329

    Over two million prescriptions for paroxetine were written for children or adolescents in the US in 2002. [29]Funded by SmithKline Beecham, the acute phase of study 329 was an eight-week, double-blind, randomized clinical trial conducted in 12 university or hospital psychiatric departments in the United States and Canada between 1994 and 1997.

  8. Glaxo (GSK)/Sanofi Delay Study on Coronavirus Vaccine ... - AOL

    www.aol.com/news/glaxo-gsk-sanofi-delay-study...

    Glaxo (GSK)/Sanofi's (SNY) adjuvanted recombinant COVID-19 vaccine candidate shows low immune response in older adults in phase I/II study. The companies will develop the vaccine with an improved ...

  9. Skycovione - Wikipedia

    en.wikipedia.org/wiki/SKYCovione

    This article about COVID-19 vaccines is a stub. You can help Wikipedia by expanding it.